The 45 active BP patients were divided into different subgroups by sex, with/without hypertension, with/without cerebrovascular disease, with/without mucosal involvement, serum CCL17 levels > or ≤549.0 pg/mL, positive/negative anti-BP180, and positive/negative anti-BP230. The gene discussed is COL17A1; the disease is cerebrovascular disorder.